津药药业
(600488)
| 流通市值：44.66亿 | | | 总市值：44.74亿 |
| 流通股本：10.92亿 | | | 总股本：10.94亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 720,977,304.79 | 718,856,391.87 | 455,312,296.06 | 551,683,077.26 |
| 应收票据及应收账款 | 410,408,236 | 429,950,533.44 | 441,696,288.02 | 501,301,401.46 |
| 其中：应收票据 | 50,000 | 0 | 300,000 | 16,680,000 |
| 应收账款 | 410,358,236 | 429,950,533.44 | 441,396,288.02 | 484,621,401.46 |
| 应收款项融资 | 181,994,903.03 | 148,378,503.93 | 156,476,228.02 | 168,703,147.92 |
| 预付款项 | 35,126,262.59 | 48,940,815.71 | 43,033,173.7 | 30,490,652.01 |
| 其他应收款合计 | 32,890,899.47 | 29,419,601.28 | 34,159,123.23 | 39,249,954.29 |
| 存货 | 737,426,737.4 | 725,581,181.43 | 937,183,078.51 | 1,007,411,487.17 |
| 其他流动资产 | 6,083,229.16 | 6,941,189.99 | 713,543.48 | 2,295,414.53 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,124,907,572.44 | 2,108,068,217.65 | 2,068,573,731.02 | 2,301,135,134.64 |
| 非流动资产: | | | | |
| 长期股权投资 | 23,099,571.95 | 22,317,200.81 | 21,531,169.43 | 21,138,935.71 |
| 其他权益工具投资 | 142,827,964.56 | 141,884,928.83 | 292,989,538.66 | 291,143,878.05 |
| 固定资产 | 2,985,481,596.17 | 3,034,612,195.93 | 3,027,868,421.99 | 3,057,869,653.27 |
| 在建工程 | 42,500,704.52 | 34,440,031.84 | 52,956,127.83 | 38,842,992.37 |
| 使用权资产 | 84,571.23 | 126,856.85 | 169,142.48 | 195,646.7 |
| 无形资产 | 306,513,031.71 | 303,657,566.24 | 279,425,263.2 | 274,924,062.86 |
| 开发支出 | 165,319,216.28 | 168,414,424.63 | 165,136,417.54 | 170,191,263.46 |
| 商誉 | - | - | 0 | - |
| 长期待摊费用 | - | 0 | 0 | - |
| 递延所得税资产 | 37,564,087.37 | 41,808,704.56 | 41,107,038.05 | 42,023,283.46 |
| 其他非流动资产 | 293,374,223.57 | 287,152,071.79 | 316,297,453.34 | 319,048,955.49 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,996,764,967.36 | 4,034,413,981.48 | 4,197,480,572.52 | 4,215,378,671.37 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 6,121,672,539.8 | 6,142,482,199.13 | 6,266,054,303.54 | 6,516,513,806.01 |
| 流动负债: | | | | |
| 短期借款 | 221,190,369.44 | 270,252,772.21 | 270,105,388.91 | 448,728,472.23 |
| 应付票据及应付账款 | 685,137,028.29 | 719,551,520.54 | 692,960,533.42 | 756,111,377.32 |
| 其中：应付票据 | 72,920,032.37 | 38,560,000 | 42,000,000 | 23,100,000 |
| 应付账款 | 612,216,995.92 | 680,991,520.54 | 650,960,533.42 | 733,011,377.32 |
| 预收款项 | 741,337.15 | 475,900.16 | 488,536.2 | 543,270.56 |
| 合同负债 | 142,225,596.37 | 137,185,487.05 | 82,850,402.86 | 106,942,903.12 |
| 应付职工薪酬 | 61,072,315.92 | 99,084,773.38 | 75,879,632.54 | 60,942,139.58 |
| 应交税费 | 31,654,111.89 | 42,826,862.52 | 46,016,655.83 | 47,602,554.35 |
| 其他应付款合计 | 265,433,784.6 | 249,821,412.28 | 292,391,629.43 | 282,852,958.21 |
| 其中:应付利息 | - | - | 70,764 | - |
| 应付股利 | 105,561.61 | 134,743.73 | 19,623,662.38 | 94,426.38 |
| 一年内到期的非流动负债 | 404,653,338.46 | 404,704,609.01 | 404,804,022.68 | 240,411,550.92 |
| 其他流动负债 | 17,295,545.78 | 16,395,611.38 | 10,605,884.68 | 12,785,701.25 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,829,403,427.9 | 1,940,298,948.53 | 1,876,102,686.55 | 1,956,920,927.54 |
| 非流动负债: | | | | |
| 长期借款 | 296,500,000 | 277,000,000 | 278,500,000 | 463,483,500 |
| 租赁负债 | - | 0 | 14,327.72 | 39,994.08 |
| 长期应付职工薪酬 | 8,060,000 | 8,060,000 | - | - |
| 递延收益 | 142,257,157.43 | 144,988,881.2 | 152,364,450.07 | 149,337,773.52 |
| 递延所得税负债 | 17,939,819.15 | 18,117,064.65 | 39,645,226.28 | 39,633,198.97 |
| 其他非流动负债 | 713,366.04 | 713,366.04 | 951,154.72 | 1,008,224 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 465,470,342.62 | 448,879,311.89 | 471,475,158.79 | 653,502,690.57 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,294,873,770.52 | 2,389,178,260.42 | 2,347,577,845.34 | 2,610,423,618.11 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,093,932,680 | 1,093,932,680 | 1,093,932,680 | 1,093,932,680 |
| 资本公积 | 322,190,215.52 | 322,190,215.52 | 323,998,519.52 | 323,662,644.02 |
| 减:库存股 | 4,726,260 | 4,726,260 | 4,726,260 | 4,726,260 |
| 其他综合收益 | 47,836,819.46 | 46,953,380.24 | 175,823,351.99 | 174,446,965.73 |
| 专项储备 | 569,044.18 | 0 | 2,776,370.69 | 3,972,061.76 |
| 盈余公积 | 242,983,821.5 | 237,483,087.4 | 240,987,321.74 | 236,464,865.04 |
| 未分配利润 | 1,310,232,370.07 | 1,257,721,088.14 | 1,289,337,096.11 | 1,265,092,149.07 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,013,018,690.73 | 2,953,554,191.3 | 3,122,129,080.05 | 3,092,845,105.62 |
| 少数股东权益 | 813,780,078.55 | 799,749,747.41 | 796,347,378.15 | 813,245,082.28 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,826,798,769.28 | 3,753,303,938.71 | 3,918,476,458.2 | 3,906,090,187.9 |
| 负债和股东权益合计 | 6,121,672,539.8 | 6,142,482,199.13 | 6,266,054,303.54 | 6,516,513,806.01 |
| 公告日期 | 2024-04-27 | 2024-03-29 | 2023-10-28 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |